Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame?

Expert Rev Respir Med. 2022 Aug;16(8):849-852. doi: 10.1080/17476348.2022.2122445. Epub 2022 Sep 15.
No abstract available

Keywords: CML; Chronic myeloid leukemia; dasatinib; lymphocytosis; pleural effusion; tyrosine kinase inhibitor.

Publication types

  • Editorial

MeSH terms

  • Adult
  • Antineoplastic Agents*
  • Child
  • Dasatinib / adverse effects
  • Humans
  • Leukemia*
  • Lymphocytosis* / chemically induced
  • Philadelphia Chromosome
  • Pleural Effusion* / chemically induced
  • Protein Kinase Inhibitors / adverse effects

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Dasatinib